NAP-CAPABIL: Pilot study of NAB-paclitaxel in combination with capecitabine as second line treatment of advanced biliary cancer.

Citation

• Aghmesheh, M., Brungs, D., Leighton, C., & Sjoquist, K. M. (2018). NAP-CAPABIL: Pilot study of NAB-paclitaxel in combination with capecitabine as second line treatment of advanced biliary cancer.. Journal of Clinical Oncology, 36(15_suppl), e16156. doi:10.1200/jco.2018.36.15_suppl.e16156

Digital Object Identifier (doi)

• 10.1200/jco.2018.36.15_suppl.e16156

Web Of Science Accession Number

Start Page

• e16156

End Page

• e16156

Volume

• 36

Issue

• 15_suppl

Abstract

UOW Authors

•   Aghmesheh, Morteza (external author)
•   Brungs, Daniel

Publication Date

• 2018

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Citation

• Aghmesheh, M., Brungs, D., Leighton, C., & Sjoquist, K. M. (2018). NAP-CAPABIL: Pilot study of NAB-paclitaxel in combination with capecitabine as second line treatment of advanced biliary cancer.. Journal of Clinical Oncology, 36(15_suppl), e16156. doi:10.1200/jco.2018.36.15_suppl.e16156

Digital Object Identifier (doi)

• 10.1200/jco.2018.36.15_suppl.e16156

Web Of Science Accession Number

Start Page

• e16156

End Page

• e16156

Volume

• 36

Issue

• 15_suppl